The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses
Open accessAbstract
Stimulant drugs such as cocaine and amphetamine are among the most commonly abused substances by schizophrenic patients. This may be due in part to aspects of the illness and treatment side effects that impel patients to use dopamine agonist drugs. Dopaminergic neural systems have been shown to mediate both stimulant drug effects and schizophrenia. Because of the hypothesized overlap in the pathophysiology of schizophrenia and the neurobiological effects of chronic stimulant use, the potential for serious complication of the primary disease by substance abuse exists. This article reviews the neurobiological mechanisms of behavioral sensitization and neurotoxicity associated with chronic stimulant administration in the context of pathophysiological theories of schizophrenia. Discussion focuses on the potential impact of stimulant use on the disease process as well as the manifest phenomenology and course of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
ROBINSON, T., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,106
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Molecular Biology of Learning: Modulation of Transmitter Release
Kandel, E. R., & Schwartz, J. H. (1982) · Science · doi:10.1126/science.6289442 · Cited by 1,551
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in Brain
Burt, D. R., Creese, I., & Snyder, S. H. (1977) · Science · doi:10.1126/science.847477 · Cited by 1,024
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
The Two-syndrome Concept: Origins and Current Status
Crow, T. J. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.471 · Cited by 839
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
Stimulants : neurochemical, behavioral, and clinical perspectives
Creese, I. (1983) · Raven Press eBooks · Cited by 698
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607 · cited 1×
“It has been hypothesized that repeated administration of stimulants may produce a supersensitive condition in the central nervous system (CNS) by upward regulation of postsynaptic DA receptors (Klawans and Margolin 1975; Dackis and Gold 1985).”
Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy
Segal, D. S., & Mandell, A. J. (1974) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(74)90060-4 · Cited by 601
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Self-citationWagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., & Westley, J. (1980) · Brain Research · doi:10.1016/0006-8993(80)91265-2 · Cited by 523
Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity
Sonsalla, P. K., Nicklas, W. J., & Heikkila, R. E. (1989) · Science · doi:10.1126/science.2563176 · Cited by 490
Ricaurte, G. A., Schuster, C. R., & Seiden, L. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90952-x · Cited by 490
Cortical Dopaminergic Involvement in Cocaine Reinforcement
Goeders, N. E., & Smith, J. E. (1983) · Science · doi:10.1126/science.6879176 · Cited by 488
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
ANGRIST, B. M., & Gershon, S. (1970) · PubMed · Cited by 477
Wyatt, R. J., Alexander, R. C., Egan, M. F., & Kirch, D. G. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90034-5 · Cited by 477
Increasing effects of repetitive cocaine administration in the rat
POST, R. M., & ROSE, H. (1976) · Nature · doi:10.1038/260731a0 · Cited by 440
Catecholamines in the Brain as Mediators of Amphetamine Psychosis
Snyder, S. H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750260021004 · Cited by 432
Kuczenski, R., & Segal, D. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Sharp, T., Zetterström, T., Ljungberg, T., & Ungerstedt, U. (1987) · Brain Research · doi:10.1016/0006-8993(87)91416-8 · Cited by 395
The Experimental Reproduction of Amphetamine Psychosis
Bell, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200010020003 · Cited by 351
Positive vs. Negative Schizophrenia: A Critical Evaluation
Andreasen, N. C. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.380 · Cited by 332
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326
Excitatory amino acids and neuropsychiatrie disorders
Olney, J. W. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90072-3 · Cited by 322
A Review of Psychoactive Substance Use and Abuse in Schizophrenia: Patterns of Drug Choice
SCHNEIER, F. R., & SIRIS, S. G. (1987) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198711000-00001 · Cited by 319
Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate
Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320023004 · Cited by 310
Cocaine psychoses: a continuum model
(1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.3.225 · Cited by 288
Sato, M., Chen, C.-C., Akiyama, K., & Otsuki, S. (1983) · PubMed · Cited by 283
Bartosik, V. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0124 · Cited by 280
Dextroamphetamine: Evaluation of Psychomimetic Properties in Man
Griffith, J. D. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200001001 · Cited by 270
Biochemistry and Behavior: Some Central Actions of Amphetamine and Antipsychotic Drugs
Groves, P. M., & Rebec, G. V. (1976) · Annual Review of Psychology · doi:10.1146/annurev.ps.27.020176.000515 · Cited by 224
Klawans, H. L. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760240053004 · Cited by 220
Development of Psychiatric Illness in Drug Abusers: Possible Role of Drug Preference
McLellan, A. T., Woody, G. E., & O'Brien, C. P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197912133012403 · Cited by 218
Robinson, T. E., & Becker, J. B. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90478-2 · Cited by 206
Methylphenidate, Dextroamphetamine, and Levamfetamine: Effects on Schizophrenic Symptoms
Janowsky, D. S. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030024003 · Cited by 205
KOLTA, M., SHREVE, P., DESOUZA, V, & URETSKY, N. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90032-2 · Cited by 199
Amphetamine Abuse: Pattern and Effects of High Doses Taken Intravenously
Kramer, J. C. (1967) · JAMA · doi:10.1001/jama.1967.03130050039011 · Cited by 197
Murray, A. M., & Waddington, J. L. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90093-9 · Cited by 188
Brain catecholamines in schizophrenia — a good case for noradrenaline
Hornykiewicz, O. (1982) · Nature · doi:10.1038/299484a0 · Cited by 182
Segal, D. S., & Kuczenski, R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39192-5 · Cited by 177
The American Psychiatric Press Textbook of Psychiatry.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-508_13 · Cited by 177
Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects
Angrist, B., Corwin, J., Bartlik, B., & Cooper, T. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90070-9 · Cited by 171
Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats
Geyer, M. A., Russo, P. V., Segal, D. S., & Kuczenski, R. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90460-6 · Cited by 161
Antelman, S. M., & Chiodo, L. A. (1981) · PubMed · Cited by 154
Nishikawa, T., Mataga, N., Takashima, M., & Toru, M. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90006-7 · Cited by 150
The functional output of the mesolimbic dopamine system
KOOB, G. F., & SWERDLOW, N. R. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42108.x · Cited by 149
Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon
Kalivas, P. W. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90004-1 · Cited by 145
Hallucinogenic drugs as precipitants of schizophrenia
Breakey, W. R., Goodell, H., Lorenz, P. C., & McHugh, P. R. (1974) · Psychological Medicine · doi:10.1017/s0033291700042938 · Cited by 143
The Dopamine Hypothesis: An Overview of Studies With Schizophrenic Patients
Haracz, J. L. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.3.438 · Cited by 139
Hirabayashi, M., & Alam, M. R. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90056-3 · Cited by 138
Selective dopamine D2 receptor reduction enhances A D1 mediated oral dyskinesia in rats
Rosengarten, H., Schweitzer, J. W., & Friedhoff, A. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90434-0 · Cited by 136
Seiden, L. S., Commins, D., Vosmer, G. L., Axt, K. J., & Marek, G. J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42104.x · Cited by 126
Presynaptic subsensitivity as a possible basis for sensitization by long-tern dopamine mimetics
Muller, P., & Seeman, P. M. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90387-x · Cited by 125
Reverse tolerance to stimulant-induced abnormal behavior
Kilbey, M. M., & Ellinwood, E. H. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90294-6 · Cited by 117
Amphetamines: Biochemical and Behavioral Actions in Animals
Moore, K. E. (1978) · Springer eBooks · doi:10.1007/978-1-4757-0510-2_2 · Cited by 113
Behavioral pharmacology of cocaine.
FAWCETT, J. A. (1988) · PubMed · Cited by 113
Cognitive therapy with schizophrenic patients
Perris, C., & Skagerlind, L. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05868.x · Cited by 112
Recent Stressful Life Events and Episodes of Schizophrenia
Dohrenwend, B. P., & Egri, G. (1981) · Schizophrenia Bulletin · doi:10.1093/schbul/7.1.12 · Cited by 112
Castañeda, E., Becker, J. B., & Robinson, T. E. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90343-8 · Cited by 110
Continuous amphetamine intoxication: an animal model of the acute psychotic episode
Ellison, G. D., & Eison, M. S. (1983) · Psychological Medicine · doi:10.1017/s003329170005145x · Cited by 109
Enhanced stereotypies after repeated injections but not continuous amphetamines
Nelson, L. R., & Ellison, G. D. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90045-x · Cited by 107
Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites
Howlett, D. R., & Nahorski, S. R. (1979) · Brain Research · doi:10.1016/0006-8993(79)90206-3 · Cited by 104
Recent psychostimulant use in hospitalized schizophrenics.
Richard, M. L., Liskow, B. I., & Perry, P. J. (1985) · PubMed · Cited by 102
d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia
van Kammen, D. P., Bunney, W. E., Docherty, J. P., Marder, S. R., Ebert, M. H., Rosenblatt, J. E., & Rayner, J. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.8.991 · Cited by 100
Kuczenski, R. T. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90270-7 · Cited by 99
Post, R. M., Weiss, S. R. B., & Pert, A. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42114.x · Cited by 94
Intravenous cocaine: Psychiatric effects, biological mechanisms
Sherer, M. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90222-3 · Cited by 93
Two dissociable components of behavioral sensitization following repeated amphetamine administration
Leith, N. J., & Kuczenski, R. T. (1982) · Psychopharmacology · doi:10.1007/bf00449116 · Cited by 89
Neuroendocrine Findings in Chronic Cocaine Abusers: A Preliminary Report
Gawin, F. H., & Kleber, H. D. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.5.569 · Cited by 85
Methylphenidate challenge as a predictor of relapse in schizophrenia
Lieberman, J. A., Kane, J. M., Gadaleta, D. J., Brenner, R., LESSER, M., & Kinon, B. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.633 · Cited by 78
Self-citationSuspiciousness Induced by Four-Hour Intravenous Infusions of Cocaine: Preliminary Findings
Sherer, M. A., Kumor, K. M., Cone, E. J., & Jaffe, J. H. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800310083010 · Cited by 76
Cognitive Therapy with Schizophrenic Patients
Magaro, P. A. (1990) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1990.44.2.296 · Cited by 73
The New Harvard guide to psychiatry
(1988) · Choice Reviews Online · doi:10.5860/choice.26-1203 · Cited by 69
Central Nervous System Stimulants: Historical Aspects and Clinical Effects
ANGRIST, B. M., & Sudilovsky, A. (1978) · Springer eBooks · doi:10.1007/978-1-4757-0510-2_3 · Cited by 64
Bailey, R. C., & Jackson, D. M. (1978) · Psychopharmacology · doi:10.1007/bf00432856 · Cited by 64
Behavioral Aberrations in Methamphetamine-intoxicated Animals and Chemical Correlates in the Brain
UTENA, H. (1966) · Progress in brain research · doi:10.1016/s0079-6123(08)64231-4 · Cited by 59
Localization of neurochemical effects of cocaine and other stimulants in the human brain.
Baxter, L. R., Schwartz, J. M., Phelps, M. E., Mazziotta, J. C., Barrio, J. R., Rawson, R. A., Engel, J., Guzé, B. H., Selin, C., & Sumida, R. (1988) · PubMed · Cited by 52
Finnegan, K. T., Ricaurte, G. A., Seiden, L. S., & Schuster, C. R. (1982) · Psychopharmacology · doi:10.1007/bf00436098 · Cited by 50
Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine
Nielsen, E. B., Nielsen, M., Ellison, G. D., & Bræstrup, C. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90137-5 · Cited by 47
Barnett, J. V., Segal, D. S., & Kuczenski, R. T. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39083-x · Cited by 45
Treatment outcome of first episode schizophrenia.
Lieberman, J. A., Jody, D. N., Geisler, S., Vital-Herne, J., Alvir, J., Walsleben, J. A., & Woerner, M. G. (1989) · PubMed · Cited by 44
Self-citationNeurobiological vulnerability to low-dose amphetamine psychosis
Gold, M. S., & Mb, B. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.12.1546 · Cited by 41
Trulson, M. E., Babb, S., Joe, J. C., & Raese, J. D. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90252-9 · Cited by 40
Kamata, K., & Rebec, G. V. (1984) · Brain Research · doi:10.1016/0006-8993(84)90691-7 · Cited by 38
Lucot, J. B., Wagner, G. C., Schuster, C. R., & Seiden, L. S. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90247-6 · Cited by 37
Amphetamine‐induced hypersensitivity in guinea pigs
Weiner, W. J., Goetz, C. G., Nausieda, P. A., & Klawans, H. L. (1979) · Neurology · doi:10.1212/wnl.29.7.1054 · Cited by 35
The American Psychiatric Press Textbook of Psychiatry
Meltzer, H. Y. (1988) · JAMA · doi:10.1001/jama.1988.03410220133047 · Cited by 31
Greenberg, B. D., & Segal, D. S. (1986) · Psychopharmacology · doi:10.1007/bf00310511 · Cited by 30
Ellinwood, E. H., & Lee, T. H. (1983) · Brain Research · doi:10.1016/0006-8993(83)90867-3 · Cited by 29
Iwamoto, E. T. (1986) · Psychopharmacology · doi:10.1007/bf00310633 · Cited by 23
Amphetamine Abuse in New York City 1966 to 1968
ANGRIST, B. M., & Gershon, S. (1969) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1969.10524419 · Cited by 22
Kuczenski, R. T. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01783.x · Cited by 21
Amphetamine Psychosis: I. Description of the Individuals and Process
Ellinwood, E. H. (1969) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1969.10524414 · Cited by 20
Akiyama, K., Sato, M., Kashihara, K., & Otsuki, S. (1982) · PubMed · Cited by 19
The New Harvard Guide to Psychiatry
Schwab, J. J. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.5.676 · Cited by 18
Chasnoff, I. J., Burns, W. J., Schnoll, S. H., et al. (1986) · Obstetric Anesthesia Digest · doi:10.1097/00132582-198603000-00003 · Cited by 18
Daiguji, M., & Meltzer, H. Y. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90222-9 · Cited by 14
Cited by
Kalivas, P. W., & Stewart, J. (1991) · Brain Research Reviews · doi:10.1016/0165-0173(91)90007-u · Cited by 2,019
The neuropsychology of schizophrenia
Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065055 · Cited by 1,350
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
The Prodromal Phase of First-episode Psychosis: Past and Current Conceptualizations
Yung, A. R., & McGorry, P. D. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.353 · Cited by 1,168
Metadata
- Authors
- Lieberman, J. A., Kinon, B. J., & Loebel, A. D.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 97-110
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2138921838
- Cited by
- 274
- References
- 102
- FWCI
- 22.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.